Nabiximols combined with motivational enhancement/cognitive behavioral therapy for the treatment of cannabis dependence: A pilot randomized clinical trial.

Jose M TrigoAlexandra SolimanLena C QuiltyBenedikt FischerJürgen RehmPeter SelbyAllan J BarnesMarilyn A HuestisTony P GeorgeDavid L StreinerGregory StaiosBernard Le Foll

Published in: PloS one (2018)

Nabiximols in combination with MET/CBT was well tolerated and allowed for reduction of cannabis use. Future clinical trials should explore the potential of high doses of nabiximols for cannabis dependence.

Keyphrases

clinical trial
tyrosine kinase
study protocol
open label
phase iii